Takeda Pharmaceutical (TKPHF) Land & Improvements (2017 - 2019)

Takeda Pharmaceutical's Land & Improvements history runs 3 years deep, the most recent figure standing at $312.1 million for Q1 2019.

• In Q1 2019, Land & Improvements changed N/A year-over-year to $312.1 million; the TTM figure through Mar 2019 stood at $312.1 million (changed N/A YoY), while the FY2019 annual figure was $312.1 million, changed N/A from the prior year.
• Land & Improvements was $312.1 million for Q1 2019 at Takeda Pharmaceutical, up from $295.6 million in the prior quarter.
• In the past five years, Land & Improvements ranged from a high of $332.3 million in Q4 2017 to a low of $295.6 million in Q4 2018.
• Historically, Land & Improvements has averaged $313.3 million across 3 years, with a median of $312.1 million in 2019.
• Biggest YoY gain for Land & Improvements was 11.04% in 2018; the steepest drop was 11.04% in 2018.
• A 3-year view of Land & Improvements shows it stood at $332.3 million in 2017, then fell by 11.04% to $295.6 million in 2018, then gained by 5.6% to $312.1 million in 2019.
• The last three Land & Improvements figures came in at $312.1 million (Q1 2019), $295.6 million (Q4 2018), and $332.3 million (Q4 2017), per Business Quant data.